Email address
[email protected]Contact number
+1 215 979 1225Share profile
Band 2
Provided by Richard Silfen
Mr. Silfen is Co-Chair of the Mergers & Acquisitions Division of the firm's Corporate Practice Group. Her regularly advises companies and their boards, as well as fund sponsors and their portfolio companies, in capital markets and other capital-raising transactions, mergers and acquisitions and control transactions.
Mr. Silfen also assists emerging and private equity-backed companies to develop plans for the growth and development of their businesses and technologies, including collaborative and strategic partnerships, and joint venture arrangements. His practice focuses include the healthcare/life sciences, fintech, cannabis and real estate sectors.
Duane Morris LLP: Partner, 2007-2014, 2015-present; VEREIT, Inc.: Executive Vice President, General Counsel and Secretary, 2014-2015; Cangen Biotechnologies, Inc.: President and Chief Financial Officer, 2004-2006; Morgan, Lewis & Bockius LLP: Partner, 2000-2004; Wolf, Block, Schorr and Solis-Cohen LLP: Vice Chairman, Corporate Department, 1999-2000, Partner, 1996-2000; Securities & Exchange Commission, Division of Corporation Finance, 1987-90: Staff Attorney, Office of Chief Counsel and Office of Mergers and Acquisitions, Attorney-Adviser, Disclosure Operations Office
GMH Communities Trust
The University of Alabama School of Law, J.D., 1987; Baylor University, B.A. (Physics), 1983
Provided by Chambers
Richard Silfen is cochair of the mergers and acquisitions division of the Duane Morris corporate practice group. He offers expertise in capital markets, private equity and M&A to clients in a broad range of industries.
Provided by Chambers
"Richard Silfen is able to advise on strategy related to financing, securities and corporate matters."
"Richard Silfen is able to advise on strategy related to financing, securities and corporate matters."
